ABT

Abbott Laboratories News

Kaufen
Verkaufen
Best deals to access real time data!
Trade Alert US
Monthly Subscription
for only
52,79 €
Real-time Level 1 for Canada + USA
Monthly Subscription
for only
32,99 €
US Markets and Indices (NYSE/NASDAQ/AMEX)
Monthly Subscription
for only
15,62 €
VAT not included
Name Symbol Markt Aktientyp
Abbott Laboratories ABT NYSE Common Stock
  Änderung Änderung % Aktuell Zeit
0,36 0,32% 112,80 01:58:01
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
113,83 110,82 113,83 113,24 112,44
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
19.5.202215:15PRNUSNew Late-Breaking Data Highlight Abbott Structural Heart..
17.5.202217:05DJNAbbott Laboratories on Pace for Largest Percent Increase..
17.5.202200:00DJNCorrection to Abbott Labs Enters Into Consent Decree with..
16.5.202223:10DJNAbbott Labs Enters Into Consent Decree with FDA For Michigan..
16.5.202222:22PRNUSAbbott Enters into Consent Decree with U.S. Food and Drug..
12.5.202214:34TRMNHow Will Baby Formula Shortage Affect Abbott?
11.5.202215:00PRNUSAbbott and Women as One Partner to Help More..
06.5.202200:17EDGARStatement of Changes in Beneficial Ownership (4)
05.5.202223:22EDGARStatement of Changes in Beneficial Ownership (4)
04.5.202215:42DJNAbbott Gets FDA Clearance for Alinity M STI Assay
04.5.202215:00PRNUSAbbott Obtains FDA Clearance for First Test that..
04.5.202200:32EDGARStatement of Changes in Beneficial Ownership (4)
04.5.202200:19EDGARStatement of Changes in Beneficial Ownership (4)
04.5.202200:10EDGARStatement of Changes in Beneficial Ownership (4)
04.5.202200:00EDGARStatement of Changes in Beneficial Ownership (4)
03.5.202223:57EDGARStatement of Changes in Beneficial Ownership (4)
03.5.202223:55EDGARStatement of Changes in Beneficial Ownership (4)
03.5.202223:52EDGARStatement of Changes in Beneficial Ownership (4)
03.5.202223:50EDGARStatement of Changes in Beneficial Ownership (4)
02.5.202222:37EDGARCurrent Report Filing (8-k)
29.4.202223:25DJNAbbott Laboratories Releasing Previously Held Formulas at..
29.4.202222:35PRNUSAbbott to Release Metabolic Nutrition Formulas
29.4.202215:00PRNUSStudy Finds 89% of Patients Treated for Persistent Atrial..
28.4.202215:00PRNUSAbbott Strengthens Left Atrial Appendage Closure Leadership..
28.4.202213:00PRNUSNew Analysis Shows that Abbott's FreeStyle Libre® System..
27.4.202214:00PRNUSAbbott, CamDiab and Ypsomed Unveil New Automated Insulin..
27.4.202206:00PRNUSAbbott, CamDiab and Ypsomed Unveil New Automated Insulin..
26.4.202215:00PRNUSAbbott Recommends Rejection of Below-Market Mini-Tender..
25.4.202215:00PRNUSAbbott Strengthens Its Connected Care Technologies with..
21.4.202216:56TRMNAbbott Rises on Q1 Earnings Beat
20.4.202214:28DJNAbbott Labs Raises 2022 Covid Testing Sales Guidance
20.4.202214:20DJNAbbott Labs Posts Higher 1Q Sales, Earnings
20.4.202213:38EDGARCurrent Report Filing (8-k)
20.4.202213:30PRNUSAbbott Reports First-Quarter 2022 Results
05.4.202211:09TRMNAbbott’s Leadless Pacemaker Gets Green Light
04.4.202215:00PRNUSAbbott Receives FDA Approval for Aveir™ VR Leadless..
01.4.202223:32EDGARStatement of Changes in Beneficial Ownership (4)
01.4.202223:25EDGARStatement of Changes in Beneficial Ownership (4)
30.3.202213:30PRNUSAbbott and LISC Team Up to Address Diversity and Equity Gaps..
28.3.202215:00PRNUSAbbott Hosts Conference Call for First-Quarter Earnings
25.3.202218:01EDGARNotice of Exempt Solicitation. Definitive Material...
24.3.202222:45SEEKAbbott granted $1B U.S. Army contract for COVID-19 test kits
24.3.202216:42SEEKAbbott's glucose monitoring system FreeStyle gets expanded..
24.3.202214:00PRNUSAbbott's FreeStyle® Libre is First and Only CGM System to..
22.3.202222:45SEEKFDA inspection found violations at Abbott infant formula..
21.3.202219:03EDGARNotice of Exempt Solicitation. Definitive Material...
18.3.202221:28EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
18.3.202221:28EDGARProxy Statement (definitive) (def 14a)
12.3.202220:20SEEKDrugmakers face clinical trial disruptions amid Russia -..
10.3.202223:26EDGARStatement of Changes in Beneficial Ownership (4)
Kürzlich von Ihnen besucht
NYSE
ABT
Abbott Lab..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

P: V: D:20220522 14:49:59